Moti Chapagain
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Viral Infections and Vectors
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Tuberculosis Research and Epidemiology 12
- Epidemiology 14
- Mycobacterium research and diagnosis 12
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Co-authors
- Vivek R. Nerurkar (5 shared papers)Saguna Verma (3 shared papers)Tawanda Gumbo (16 shared papers)Ulziijargal Gurjav (2 shared papers)Rajendra Gautam (4 shared papers)Sony Shrestha (4 shared papers)Hari Prasad Nepal (4 shared papers)Shamshul Ansari (4 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)The Journal of Infectious Diseases (2 papers)Virology (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesSouth AfricaNepal
In The Last Decade
Moti Chapagain
26 papers receiving 836 citations
Peers
Comparison fields: 5 of 93
- Molecular Medicine 104
- Infectious Diseases 369
- Applied Microbiology and Biotechnology 39
- Clinical Biochemistry 55
- Oncology 189
Countries citing papers authored by Moti Chapagain
This map shows the geographic impact of Moti Chapagain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moti Chapagain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moti Chapagain more than expected).
Fields of papers citing papers by Moti Chapagain
This network shows the impact of papers produced by Moti Chapagain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moti Chapagain. The network helps show where Moti Chapagain may publish in the future.
Co-authors
The 25 scholars most cited alongside Moti Chapagain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 197 | |
| 2 | 2010 | 94 | |
| 3 | 2014 | 69 | |
| 4 | 2007 | 64 | |
| 5 | 2015 | 56 | |
| 6 | 2018 | 54 | |
| 7 | 2017 | 51 | |
| 8 | 2011 | 47 | |
| 9 | 2015 | 41 | |
| 10 | 2017 | 32 | |
| 11 | 2008 | 27 | |
| 12 | 2006 | 24 | |
| 13 | 2022 | 21 | |
| 14 | 2020 | 17 | |
| 15 | 2014 | 12 | |
| 16 | 2020 | 12 | |
| 17 | 2020 | 9 | |
| 18 | 2021 | 7 | |
| 19 | 2021 | 7 | |
| 20 | 2020 | 4 |
About Moti Chapagain
Moti Chapagain is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Oncology and Electrical and Electronic Engineering, having authored 26 papers that have together received 858 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (12 papers), Polyomavirus and related diseases (4 papers), Full-Duplex Wireless Communications (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers), Quinazolinone synthesis and applications (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Molecular Medicine (104 citations), Infectious Diseases (369 citations), Applied Microbiology and Biotechnology (39 citations), Clinical Biochemistry (55 citations) and Oncology (189 citations). Moti Chapagain has collaborated with scholars based in United States, South Africa and Nepal. Frequent co-authors include Vivek R. Nerurkar, Saguna Verma, Tawanda Gumbo, Ulziijargal Gurjav, Rajendra Gautam, Sony Shrestha, Hari Prasad Nepal, Shamshul Ansari, Mukesh Kumar and Shashikant Srivastava. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Virology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.